Inventurus Knowledge Solutions has approved a further investment of up to USD 40 million in its wholly owned subsidiary, Inventurus Knowledge Solutions Inc. (IKS Inc), as part of its ongoing strategic growth initiatives.
The decision was made during the company’s board meeting held on 13 March 2026. The investment will be executed in two tranches, with the first USD 20 million tranche priced at USD 643.19 per share, expected to be completed by 31 May 2026.
IKS Inc, based in the United States, specialises in providing technology-enabled solutions for healthcare providers through its care enablement platform. For the fiscal year 2024-25, IKS Inc reported a revenue of ₹6,941.11 million from operations and a total income of ₹6,996.92 million.
This transaction, conducted on an arm’s length basis, does not involve any interest from the company’s promoter group. The investment aims to support the business activities of IKS Inc, further enhancing its capabilities in the healthcare technology sector.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).